Tolerance and cross-tolerance following toll- like receptor (TLR)-4 and -9 activation are mediated by IRAK-M and modulated by IL-7 in murine splenocytes

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Julian, Mark W ^a   Strange, Heather R ^b   Ballinger, Megan N ^a   Hotchkiss, Richard S ^c   Papenfuss, Tracey L ^b   Crouser, Elliott D ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; INTERLEUKIN 10; INTERLEUKIN 7; PROGRAMMED DEATH 1 RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; CPG-OLIGONUCLEOTIDE; IL10 PROTEIN, MOUSE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN-7, MOUSE; IRAK3 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE; OLIGODEOXYRIBONUCLEOTIDE; TLR4 PROTEIN, MOUSE; TLR9 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INTERACTION; CELL POPULATION; CELL VIABILITY; CONTROLLED STUDY; CPG ISLAND; CROSS TOLERANCE; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REPRESSION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SPLEEN CELL; WESTERN BLOTTING; ANIMAL; CYTOLOGY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; SPLEEN;

ANIMALS; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-10; INTERLEUKIN-7; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, KNOCKOUT; OLIGODEOXYRIBONUCLEOTIDES; SPLEEN; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84941671121     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132921     Document Type: Article

References (72)

1. Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, Ren T, et al. Induction of in vitro reprogramming by Toll-Like Receptor (TLR)2 and TLR4 agonists in murine macrophages: Effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. J Immunol. 2003; 170:508-519. PMID: 12496438.
2. Draisma A, Pickkers P, Bouw MP, van der Hoeven JG. Development of endotoxin tolerance in humans in vivo. Crit Care Med. 2009; 37:1261-1267. doi:10.1097/CCM.0b013e31819c3c67 PMID: 19242351.
3. Castegren M, Skorup P, Lipcsey M, Larsson A, Sjolin J. Endotoxin tolerance variation over 24 h during porcine endotoxemia: Association with changes in circulation and organ dysfunction. PLoS One. 2013; 8:e53221. doi:10.1371/journal.pone.0053221 PMID: 23326400.
4. Leentjens J, Kox M, Koch RM, Preijers F, Joosten LA, van der Hoeven JG, et al. Reversal of immunoparalysis in humans in vivo; a double-blind, placebo-controlled, randomized pilot study. Am J Respir Crit Care Med. 2012; 186:838-845. doi:10.1164/rccm.201204-0645OC PMID: 22822024.
5. Dalpke AH, Lehner MD, Hartung T, Heeg K. Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance. Immunology. 2005; 116:203-212. PMID: 16162269.
6. Faust SM, Bell P, Cutler BJ, Ashley SN, Zhu Y, Rabinowitz JE, et al. CpG-depleted adeno-associated virus vectors evade immune detection. J Clin Invest. 2013; 123:2994-3001. doi:10.1172/JCI68205 PMID: 23778142.
7. Zhu J, Huang X, Yang Y. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and-independent pathways. J Virology. 2007; 81:3170-3180. PMID: 17229689.
8. Sieben M, Schafer P, Dinsart C, Galle PR, Moehler M. Activation of the human immune system via tolllike receptors by the oncolytic parvovirus H-1. Int J Cancer. 2013; 132:2548-2556. doi:10.1002/ijc.27938 PMID: 23151948.
9. Boehme KW, Compton T. Innate sensing of viruses by Toll-like receptors. J Virology. 2004; 78:7867- 7873. PMID: 15254159.
10. Iversen AC, Steinkjer B, Nilsen N, Bohnhorst J, Moen SH, Vik R, et al. A proviral role for CpG in cytomegalovirus infection. J Immunol. 2009; 182:5672-5681. doi:10.4049/jimmunol.0801268 PMID: 19380814.
11. Julian MW, Shao G, Bao S, Knoell DL, Papenfuss TL, VanGundy ZC, et al. Mitochondrial transcription factor A serves as a danger signal by augmenting plasmacytoid dendritic cell responses to DNA. J Immunol. 2012; 189:433-443. doi:10.4049/jimmunol.1101375 PMID: 22675199.
12. Yeo SJ, Yoon JG, Hong SC, Yi AK. CpG DNA induces self and cross-hyporesponsiveness of RAW264.7 cells in response to CpG DNA and lipopolysaccharide: Alterations in IL-1 receptor-associated kinase expression. J Immunol. 2003; 170:1052-1061. PMID: 12517973.
13. Van't Veer C, van den Pangaart PS, van Zoelen MA, de Kruif M, Birjmohun RS, Stroes ES, et al. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J Immunol. 2007; 179:7110-7120. PMID: 17982103.
14. Zhou H, Yu M, Fukuda K, Im J, Yao P, Cui W, et al. IRAK-M mediates Toll-like receptor/IL-1R-induced NFκB activation and cytokine production. EMBO J 2013; 32:583-596. doi:10.1038/emboj.2013.2 PMID: 23376919.
15. Hutchins NA, Unsinger J, Hotchkiss RS, Ayala A. The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol Med. 2014; 20:224-233. doi:10.1016/j.molmed.2014.01.002 PMID: 24485901.
16. Kobayashi T, Matsuoka K, Sheikh SZ, Russo SM, Mishima Y, Collins C, et al. IL-10 regulates IL12b expression via histone deacetylation: implications for intestinal macrophage homeostasis. J Immunol. 2012; 189:1792-1799. doi:10.4049/jimmunol.1200042 PMID: 22786766.
17. Akiyama K, Chen C, Wang D, Xu X, Qu C, Yamaza T, et al. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell. 2012; 10:544-555. doi:10.1016/j.stem.2012.03.007 PMID: 22542159.
18. Kroemer G, Cuende E, Martinez C. Compartmentalization of the peripheral immune system. Adv Immunol. 1993; 53:157-216. PMID: 8512035.
19. Cook CH. Cytomegalovirus reactivation in "immunocompetent" patients: A call for scientific prophylaxis. J Infect Dis. 2007; 196:1273-1275. PMID: 17922387.
20. Leentjens J, Kox M, van der Hoeven JG, Netea MG, Pickkers P. Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? Am J Respir Crit Care Med. 2013; 187:1287-1293. doi:10.1164/rccm.201301-0036CP PMID: 23590272.
21. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013; 13:862-874. doi:10.1038/nri3552 PMID: 24232462.
22. Boomer JS, Green JM, Hotchkiss RS. The changing immune system in sepsis: Is individualized immune-modulatory therapy the answer? Virulence. 2014; 5:45-56. doi:10.4161/viru.26516 PMID: 24067565.
23. Shindo Y, Unsinger J, Burnham CA, Green JM, Hotchkiss RS. Interleukin 7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression. Shock 2015; Jan 6 [Epub ahead of print]. doi:10.1097/SHK.0000000000000317.
24. Mach N, Gillessen S, Wilson SB, Sheehan C, Mihm M, Dranoff G. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Res. 2000; 60:3239-3246. PMID: 10866317.
25. Papenfuss TL, Kithcart AP, Powell ND, McClain MA, Gienapp IE, Shawler TM, et al. Disease-modifying capability of murine Flt3-ligand DCs in experimental autoimmune encephalomyelitis. J Leukoc Biol. 2007; 82:1510-1518. PMID: 17855499.
26. Julian MW, Shao G, Van Gundy ZC, Papenfuss TL, Crouser ED. Mitochondrial transcription factor A, an endogenous danger signal, promotes TNFα release via RAGE- And TLR9-responsive plasmacytoid dendritic cells. PLoS One. 2013; 8:e72354. doi:10.1371/journal.pone.0072354 PMID: 23951313.
27. Kobayashi K, Hernandez LD, Galán JE, Janeway CA Jr, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell. 2002; 110:191-202. PMID: 12150927.
28. Ballinger MN, Newstead MW, Zeng X, Bhan U, Horowitz JC, Moore BB, et al. TLR signaling prevents hyperoxia-induced lung injury by protecting alveolar epithelium from oxidant-mediated death. J Immunol. 2012; 189:356-364. doi:10.4049/jimmunol.1103124 PMID: 22661086.
29. Ferguson RE, Carroll HP, Harris A, Maher ER, Selby PJ, Bank RE. Housekeeping proteins: A preliminary study illustrating some limitations as useful references in protein expression studies. Proteomics. 2005; 5:566-571. PMID: 15627964.
30. Venet F, Foray AP, Villars-Mechin A, Malcus C, Poitevin-Later F, Lepape A, et al. IL-7 restores lymphocyte functions in septic patients. J Immunol. 2012; 189:5073-5081. doi:10.4049/jimmunol.1202062 PMID: 23053510.
31. Koenen P, Heinzel S, Carrington EM, Happo L, Alexander WS, Zhang JG, et al. Mutually exclusive regulation of T cell survival by IL-7R and antigen receptor-induced signals. Nat Commun. 2013; 4:1735. doi:10.1038/ncomms2719 PMID: 23591902.
32. Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med. 1997; 25:1813-1819. PMID: 9366763.
33. Rixen D, Siegel JH, Friedman HP. "Sepsis/SIRS", physiologic classification, severity stratification, relation to cytokine elaboration and outcome in posttrauma critical illness. J Trauma. 1996; 41: 581-598. PMID: 8858015.
34. Xiong Y, Pennini M, Vogel SN, Medvedev AE. IRAK4 kinase activity is not required for induction of endotoxin tolerance but contributes to TLR2-mediated tolerance. J Leukoc Biol. 2013; 94:291-300. doi:10.1189/jlb.0812401 PMID: 23695305.
35. Kawasaki T, Ogata M, Kawasaki C, Tomihisa T, Okamoto K, Shigematsu A. Surgical stress induces endotoxin hyporesponsiveness and an early decrease of monocyte mCD14 and HLA-DR expression during surgery. Anesth Analg. 2001; 92:1322-1326. PMID: 11323370.
36. Heagy W, Nieman K, Hansen C, Cohen M, Danielson D, West MA. Lower levels of whole blood LPSstimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients. Surgical Infections. 2003; 4:171-180. PMID: 12906717.
37. Heagy W, Hansen C, Nieman K, Cohen M, Richardson C, Rodriguez JL, et al. Impaired ex vivo lipopolysaccharide- stimulated whole blood tumor necrosis factor production may identify "septic" intensive care unit patients. Shock. 2000; 14:271-276. PMID: 11028542.
38. Xiong Y, Medvedev AE. Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20. J Leukoc Biol. 2011; 90:1141-1148. doi:10.1189/jlb.0611273 PMID: 21934070.
39. O'Brien AD, Rosenstreich DL, Scher I, Campbell GH, MacDermott RP, Formal SB. Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J Immunol. 1980; 124:20-24. PMID: 6985638.
40. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Int Med. 2002; 162:1028-1032.
41. Weijer S, Lauw FN, Branger J, van den Blink B, van der Poll T. Diminished interferon-γ production and responsiveness after endotoxin administration to healthy humans. J Infect Dis. 2002; 186:1748-1753. PMID: 12447760.
42. Wurzel DF, Mackay IM, Marchant JM, Wang CY, Yerkovich ST, Upham JW, et al. Adenovirus species C is associated with chronic suppurative lung diseases in children. Clin Infect Dis. 2014; 59:34-40. doi:10.1093/cid/ciu225 PMID: 24748519.
43. Techasaensiri B, Techasaensiri C, Mejias A, McCracken GM Jr, Ramilo O. Viral coinfections in children with invasive pneumococcal disease. Pediatr Infect Dis J. 2010; 29:519-523. doi:10.1097/INF.0b013e3181cdafc2 PMID: 20051928.
44. Zhou F, Ciric B, Li H, Yan Y, Li K, Cullimore M, et al. IL-10 deficiency blocks the ability of LPS to regulate expression of tolerance-related molecules on dendritic cells. Eur J Immunol. 2012; 42:1449-1458. doi:10.1002/eji.201141733 PMID: 22622800.
45. Jiang HR, Muckersie E, Robertson M, Xu H, Liversidge J, Forrester JV. Secretion of interleukin-10 or interleukin-12 by LPS-activated dendritic cells is critically dependent on time of stimulus relative to initiation of purified DC culture. J Leukoc Biol. 2002; 72:978-985. PMID: 12429720.
46. Van der Sluijs KF, van Elden LJ, Nijhuis M, Schuurman R, Pater JM, Florquin S, et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol. 2004; 172:7603-7609. PMID: 15187140.
47. Dolgachev VA, Yu B, Reinke JM, Raghavendran K, Hemmila MR. Host susceptibility to gram-negative pneumonia after lung contusion. J Trauma Acute Care Surg. 2012; 72:614-623. doi:10.1097/TA.0b013e318243d9b1 PMID: 22491544.
48. Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010; 10:826-837. doi:10.1038/nri2873 PMID: 21088683.
49. Lee N, Wong CK, Hui DS, Lee SK, Wong RY, Ngai KL, et al. Role of human Toll-like receptors in naturally occurring influenza A infections. Influenza Other Respir Viruses. 2013; 7:666-675. doi:10.1111/irv.12109 PMID: 23552014.
50. Torcia MG, Nencioni L, Clemente AM, Civitelli L, Celestino I, Limongi D, et al. Sex differences in the response to viral infections: TLR8 and TLR9 ligand stimulation induce higher IL10 production in males. PLoS One. 2012; 7:e39853. doi:10.1371/journal.pone.0039853 PMID: 22768144.
51. Cho HY, Choi EK, Lee SW, Jung KO, Seo SK, Choi IW, et al. Programmed death-1 receptor negatively regulates LPS-mediated IL-12 production and differentiation of murine macrophage RAW264.7 cells. Immunol Lett. 2009; 127:39-47. doi:10.1016/j.imlet.2009.08.011 PMID: 19723542.
52. Zhang Y, Zhou Y, Lou J, Li J, Bo L, Zhu K, et al. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit Care. 2010; 14:R220. doi:10.1186/cc9354 PMID: 21118528.
53. Chang K, Svabek C, Vazquez-Guillamet C, Sato B, Rasche D, Wilson S, et al. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care. 2014; 18:R3. doi:10.1186/cc13176 PMID: 24387680.
54. Zhang Y, Li J, Lou J, Zhou Y, Bo L, Zhu J, et al. Upregulation of programmed death-1 on T cells and programmed cell death ligand-1 on monocytes in septic shock patients. Crit Care. 2011; 15:R70. doi:10.1186/cc10059 PMID: 21349174.
55. Chemnitz JM, Parry RV, Nichols KE, June CH, Riley JL. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol. 2004; 173:945-954. PMID: 15240681.
56. Li L, Masucci MG, Levitsky V. Effect of interleukin-7 on the in vitro development and maturation of monocyte derived human dendritic cells. Scand J Immunol. 2000; 51:361-371. PMID: 10736108.
57. Miller ML, Mashayekhi M, Chen L, Zhou P, Liu X, Michelotti M, et al. Basal NF-κB controls IL-7 responsiveness of quiescent naïve T cells. Proc Natl Acad Sci USA 2014; 111:7397-7402. doi:10.1073/pnas.1315398111 PMID: 24799710.
58. Nalos M, Santner-Nanan B, Parnell G, Tang B, McLean AS, Nanan R. Immune effects of interferon gamma in persistent staphylococcal sepsis. Am J Respir Crit Care Med. 2012; 185:110-112. PMID: 22210794.
59. Liu ZJ, Yan LN, Li XH, Xu FL, Chen XF, You HB, et al. Up-regulation of IRAK-M is essential for endotoxin tolerance induced by a low dose of lipopolysaccharide in Kupffer cells. J Surg Res. 2008; 150:34-39. doi:10.1016/j.jss.2007.12.759 PMID: 18533191.
60. Kim YI, Park JE, Martinez-Hernandez A, Yi AK. CpG DNA prevents liver injury and shock-mediated death by modulating expression of interleukin-1 receptor-associated kinases. J Biol Chem. 2008; 283:15258-15270. doi:10.1074/jbc.M709549200 PMID: 18378686.
61. Nahid MA, Yao B, Dominquez-Gutierrez PR, Kesavalu L, Satoh M, Chan EK. Regulation of TLR2-mediated tolerance and cross-tolerance through IRAK4 modulation by miR-132 and miR-212. J Immunol. 2013; 190:1250-1263. doi:10.4049/jimmunol.1103060 PMID: 23264652.
62. Nahid MA, Satoh M, Chan EK. Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J Immunol. 2011; 186:1723-1734. doi:10.4049/jimmunol.1002311 PMID: 21178010.
63. Sly LM, Rauh MJ, Kalesnikoff J, Song CH, Krystal G. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 2004; 21: 227-239.
64. Nakagawa R, Naka T, Tsutsui H, Fujimoto M, Kimura A, Abe T, et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 2002; 17:677-687. PMID: 12433373.
65. Parra M, Yang AL, Lim J, Kolibab K, Derrick S, Cadieux N, et al. Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis. Clin Vaccine Immunol. 2009; 16:1025-1032. doi:10.1128/CVI.00067-09 PMID: 19458207.
66. Turner DJ, Hoyle SL, Snewin VA, Gares MP, Brown IN, Young DB. An ex vivo culture model for screening drug activity against in vivo phenotypes of Mycobacterium tuberculosis. Microbiology. 2002; 148:2929-2936. PMID: 12368426.
67. Dorner BG, Scheffold A, Rolph MS, Huser MB, Kaufmann SH, Radbruch A, et al. MIP-1α, MIP-1β, RANTES, and ATAC/lymphotactin function together with IFN-γ as type 1 cytokines. PNAS. 2002; 99:6181-6186. PMID: 11972057.
68. Ilyinskii PO, Wang R, Balk SP, Exley MA. CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMVC) in vitro and immune response to EMCV infection in vivo. J Virol. 2006; 80:7146-7158. PMID: 16809320.
69. Yue SC, Nowak M, Shaulov-Kask A, Wang R, Yue D, Balk SP, et al. Direct CD1d-mediated stimulation of APC IL-12 production and protective immune response to virus infection in vivo. J Immunol. 2010; 184:268-276. doi:10.4049/jimmunol.0800924 PMID: 19949077.
70. Guillerey C, Mouries J, Polo G, Doyen N, Law HK, Chan S, et al. Pivotal role of plasmacytoid dendritic cells in inflammation and NK-cell responses after TLR9 triggering in mice. Blood. 2012; 120:90-99. doi:10.1182/blood-2012-02-410936 PMID: 22611152.
71. Perona-Wright G, Jenkins SJ, Crawford A, Gray D, Pearce EJ, MacDonald AS. Distinct sources and targets of IL-10 during dendritic cell-driven Th1 and Th2 responses in vivo. Eur J Immunol. 2006; 36:2367-2375. PMID: 16917957.
72. Souza-Fonseca-Guimaraes F, Parlato M, Fitting C, Cavaillon JM, Adib-Cunquy M. NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis. J Immunol. 2012; 188:5850- 5858. doi:10.4049/jimmunol.1103616 PMID: 22566566.